Unknown

Dataset Information

0

AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer.


ABSTRACT: Pancreatic ductal adenocarcinoma (PDA), a leading cause of cancer-related death in the United States, has a high metastatic rate, and is associated with persistent immune suppression. AXL, a member of the TAM (TYRO3, AXL, MERTK) receptor tyrosine kinase family, is a driver of metastasis and immune suppression in multiple cancer types. Here we use single-cell RNA-sequencing to reveal that AXL is expressed highly in tumor cells that have a mesenchymal-like phenotype and that AXL expression correlates with classic markers of epithelial-to-mesenchymal transition. We demonstrate that AXL deficiency extends survival, reduces primary and metastatic burden, and enhances sensitivity to gemcitabine in an autochthonous model of PDA. PDA in AXL-deficient mice displayed a more differentiated histology, higher nucleoside transporter expression, and a more active immune microenvironment compared with PDA in wild-type mice. Finally, we demonstrate that AXL-positive poorly differentiated tumor cells are critical for PDA progression and metastasis, emphasizing the potential of AXL as a therapeutic target in PDA. IMPLICATIONS: These studies implicate AXL as a marker of undifferentiated PDA cells and a target for therapy.

SUBMITTER: Du W 

PROVIDER: S-EPMC8349827 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4572915 | biostudies-literature
| S-EPMC5630395 | biostudies-literature
| S-EPMC3735500 | biostudies-literature
| S-EPMC6538328 | biostudies-literature
| S-EPMC8742768 | biostudies-literature
| S-EPMC3777608 | biostudies-literature
| S-EPMC5726277 | biostudies-literature
| S-EPMC7163446 | biostudies-literature
| S-EPMC7056881 | biostudies-literature
| S-EPMC4196166 | biostudies-literature